FTSE in positive territory

Pharmaceuticals firm Shire injected enthusiasm into London shares today as investors welcomed news it had settled a patent dispute.

FTSE in positive territory

Pharmaceuticals firm Shire injected enthusiasm into London shares today as investors welcomed news it had settled a patent dispute.

Shire’s market value lifted 7% after it revealed US group Impax would be allowed to make generic versions of Adderall XR by 2010 and would pay Shire a royalty from the sales.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited